BACKGROUND: Major depressive disorder (MDD) has been associated with changes in mean telomere length and mitochondrial DNA (mtDNA) copy number. This study investigates if clinical features of MDD differentially impact these molecular markers. METHODS: Data from a large, clinically ascertained sample of Han Chinese women with recurrent MDD were used to examine whether symptom presentation, severity, and comorbidity were related to salivary telomere length and/or mtDNA copy number (maximum N = 5,284 for both molecular and phenotypic data). RESULTS: Structural equation modeling revealed that duration of longest episode was positively associated with mtDNA copy number, while earlier age of onset of most severe episode and a history of dysthymia were associated with shorter telomeres. Other factors, such as symptom presentation, family history of depression, and other comorbid internalizing disorders, were not associated with these molecular markers. CONCLUSIONS: Chronicity of depressive symptoms is related to more pronounced telomere shortening and increased mtDNA copy number among individuals with a history of recurrent MDD. As these molecular markers have previously been implicated in physiological aging and morbidity, individuals who experience prolonged depressive symptoms are potentially at greater risk of adverse medical outcomes.
BACKGROUND: Major depressive disorder (MDD) has been associated with changes in mean telomere length and mitochondrial DNA (mtDNA) copy number. This study investigates if clinical features of MDD differentially impact these molecular markers. METHODS: Data from a large, clinically ascertained sample of Han Chinese women with recurrent MDD were used to examine whether symptom presentation, severity, and comorbidity were related to salivary telomere length and/or mtDNA copy number (maximum N = 5,284 for both molecular and phenotypic data). RESULTS: Structural equation modeling revealed that duration of longest episode was positively associated with mtDNA copy number, while earlier age of onset of most severe episode and a history of dysthymia were associated with shorter telomeres. Other factors, such as symptom presentation, family history of depression, and other comorbid internalizing disorders, were not associated with these molecular markers. CONCLUSIONS: Chronicity of depressive symptoms is related to more pronounced telomere shortening and increased mtDNA copy number among individuals with a history of recurrent MDD. As these molecular markers have previously been implicated in physiological aging and morbidity, individuals who experience prolonged depressive symptoms are potentially at greater risk of adverse medical outcomes.
Authors: G Kopsidas; S A Kovalenko; D R Heffernan; N Yarovaya; L Kramarova; D Stojanovski; J Borg; M M Islam; A Caragounis; A W Linnane Journal: Ann N Y Acad Sci Date: 2000-06 Impact factor: 5.691
Authors: I Shalev; T E Moffitt; K Sugden; B Williams; R M Houts; A Danese; J Mill; L Arseneault; A Caspi Journal: Mol Psychiatry Date: 2012-04-24 Impact factor: 15.992
Authors: Dean Ornish; Jue Lin; Jennifer Daubenmier; Gerdi Weidner; Elissa Epel; Colleen Kemp; Mark Jesus M Magbanua; Ruth Marlin; Loren Yglecias; Peter R Carroll; Elizabeth H Blackburn Journal: Lancet Oncol Date: 2008-09-15 Impact factor: 41.316
Authors: Anna R Docherty; Alexis C Edwards; Fuzhong Yang; Roseann E Peterson; Chelsea Sawyers; Daniel E Adkins; Ashlee A Moore; Bradley T Webb; Silviu A Bacanu; Jonathan Flint; Kenneth S Kendler Journal: Depress Anxiety Date: 2017-02-02 Impact factor: 6.505
Authors: J E Verhoeven; D Révész; M Picard; E E Epel; O M Wolkowitz; K A Matthews; B W J H Penninx; E Puterman Journal: Mol Psychiatry Date: 2017-03-28 Impact factor: 15.992
Authors: Olga Tymofiyeva; Eva Henje Blom; Tiffany C Ho; Colm G Connolly; Daniel Lindqvist; Owen M Wolkowitz; Jue Lin; Kaja Z LeWinn; Matthew D Sacchet; Laura K M Han; Justin P Yuan; Sarina P Bhandari; Duan Xu; Tony T Yang Journal: J Affect Disord Date: 2018-02-17 Impact factor: 4.839
Authors: Shun-Chiao Chang; Marta Crous-Bou; Jennifer Prescott; Bernard Rosner; Naomi M Simon; Wei Wang; Immaculata De Vivo; Olivia I Okereke Journal: Psychoneuroendocrinology Date: 2018-01-09 Impact factor: 4.905
Authors: Kathryn L Humphreys; Lucinda M Sisk; Erika M Manczak; Jue Lin; Ian H Gotlib Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-10-16 Impact factor: 8.829
Authors: Jonatan A Mendoza-Ortega; Enrique Reyes-Muñoz; Sonia Nava-Salazar; Sandra Rodríguez-Martínez; Sandra B Parra-Hernández; Lourdes Schnaas; Blanca Vianey Suárez-Rico; Libni A Torres-Olascoaga; Andrea A Baccarelli; Rosalind J Wright; Robert O Wright; Guadalupe Estrada-Gutierrez; Marcela Tamayo-Ortiz Journal: Int J Environ Res Public Health Date: 2021-11-10 Impact factor: 3.390
Authors: Na Cai; Monika Fňašková; Klára Konečná; Miloslava Fojtová; Jiří Fajkus; Eve Coomber; Stephen Watt; Nicole Soranzo; Marek Preiss; Ivan Rektor Journal: Front Genet Date: 2020-03-03 Impact factor: 4.599